Aaron Sosa, M.D.

Dr. Aaron Sosa is a highly skilled Medical Oncologist and experienced EU regulator, with a unique combination of clinical expertise and in-depth knowledge of medicinal product regulation. Over the course of a multifaceted career, he has bridged the gap between patient care and regulatory science, driving the approval and clinical development of cancer therapies across Europe. His expertise empowers him to optimize clinical development strategies, ensure regulatory compliance, and facilitate market access for innovative medicinal products.

Work Experience 
Dr. Sosa's career began as an Oncologist specializing in thoracic malignancies, providing him with deep insights into cancer care and research. He transitioned to the regulatory field, working at the Danish Medicines Agency and representing Denmark at EMA's Scientific Advice Working Party, where he provided expert guidance on clinical development of new cancer therapies. As Denmark's alternate CHMP member, he oversaw the agency's Oncology and Hematology product portfolio and participated in regulatory decisions at EMA. Dr. Sosa's unique blend of clinical and regulatory expertise has positioned him as a key contributor to EU policies and regulatory guidelines, shaping the future of cancer treatment.

Education
Dr. Sosa's medical education and training span multiple prestigious institutions across Guatemala, Spain, and the United States, including specialties in Medical Oncology and Internal Medicine. His career progression includes roles as Chief Resident at Hospital Clinic de Barcelona and Hospital Roosevelt, as well as clinical experience at institutions like the University of Chicago Medical Center and Children's Hospital Boston.